valyl-glycyl-valyl-alanyl-prolyl-glycine has been researched along with nifedipine in 1 studies
Studies (valyl-glycyl-valyl-alanyl-prolyl-glycine) | Trials (valyl-glycyl-valyl-alanyl-prolyl-glycine) | Recent Studies (post-2010) (valyl-glycyl-valyl-alanyl-prolyl-glycine) | Studies (nifedipine) | Trials (nifedipine) | Recent Studies (post-2010) (nifedipine) |
---|---|---|---|---|---|
37 | 1 | 19 | 16,024 | 2,496 | 1,505 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Skóra, B; Szychowski, KA; Tabęcka-Łonczyńska, A | 1 |
1 other study(ies) available for valyl-glycyl-valyl-alanyl-prolyl-glycine and nifedipine
Article | Year |
---|---|
Calcium channel antagonists interfere with the mechanism of action of elastin-derived peptide VGVAPG in mouse cortical astrocytes in vitro.
Topics: Animals; Astrocytes; Calcium Channel Blockers; Dizocilpine Maleate; Elastin; Humans; Inflammation; Mice; Neuroblastoma; Nifedipine; Oligopeptides; Peptides; PPAR gamma; Reactive Oxygen Species; Superoxide Dismutase-1; Verapamil | 2022 |